Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boring

Showing results (301-310 of 311) with videos related to

Pageof 32
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Joel M Reid, Chad A Walden, Rui Qin, et al.
American Journal of Physiology. Renal Physiology|August 30, 2013
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin miceTimothy Sullivan, Zhenhua Miao, Daniel J Dairaghi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2012
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complicationsTimothy J Sullivan, Daniel J Dairaghi, Antoni Krasinski, et al.
Nature Medicine|January 22, 2021
Effect of a plant-based, low-fat diet versus an animal-based, ketogenic diet on ad libitum energy intakeKevin D Hall, Juen Guo, Amber B Courville, et al.
Journal of Environmental Quality|October 16, 2024
The LTAR Cropland Common Experiment at the Kellogg Biological StationG Philip Robertson, Brook Wilke, Tayler Ulbrich, et al.
Obstetrics and Gynecology|November 9, 2016
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of PregnancyKenneth J Moise, Manisha Gandhi, Noemi H Boring, et al.
American Journal of Human Genetics|May 29, 2018
Risks and Recommendations in Prenatally Detected De Novo Balanced Chromosomal Rearrangements from Assessment of Long-Term OutcomesChristina Halgren, Nete M Nielsen, Lusine Nazaryan-Petersen, et al.
Plos One|July 11, 2022
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizerRobert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Development of a novel, pan-variant aerosol intervention for COVID-19Robert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
The Science of the Total Environment|June 20, 2020
Integration of ecosystem science into radioecology: A consensus perspectiveOlin E Rhodes, Francois Bréchignac, Clare Bradshaw, et al.
Pageof 32

Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Joel M Reid, Chad A Walden, Rui Qin, et al.
American Journal of Physiology. Renal Physiology|August 30, 2013
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin miceTimothy Sullivan, Zhenhua Miao, Daniel J Dairaghi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2012
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complicationsTimothy J Sullivan, Daniel J Dairaghi, Antoni Krasinski, et al.
Nature Medicine|January 22, 2021
Effect of a plant-based, low-fat diet versus an animal-based, ketogenic diet on ad libitum energy intakeKevin D Hall, Juen Guo, Amber B Courville, et al.
Journal of Environmental Quality|October 16, 2024
The LTAR Cropland Common Experiment at the Kellogg Biological StationG Philip Robertson, Brook Wilke, Tayler Ulbrich, et al.
Obstetrics and Gynecology|November 9, 2016
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of PregnancyKenneth J Moise, Manisha Gandhi, Noemi H Boring, et al.
American Journal of Human Genetics|May 29, 2018
Risks and Recommendations in Prenatally Detected De Novo Balanced Chromosomal Rearrangements from Assessment of Long-Term OutcomesChristina Halgren, Nete M Nielsen, Lusine Nazaryan-Petersen, et al.
Plos One|July 11, 2022
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizerRobert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Development of a novel, pan-variant aerosol intervention for COVID-19Robert H Shoemaker, Reynold A Panettieri, Steven K Libutti, et al.
The Science of the Total Environment|June 20, 2020
Integration of ecosystem science into radioecology: A consensus perspectiveOlin E Rhodes, Francois Bréchignac, Clare Bradshaw, et al.
Pageof 32